Allergic Conjunctivitis Market, By Type (Bacterial, Allergic, Viral, and Chemical), By Drug Class (Antibiotics, Mast Cell Stabilizers, Steroids, and Others), By End Users (Hospitals and Clinics and Specialty Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2029

Report Code: PMI448920 | Publish Date: June 2023 | No. of Pages: 170

Global Allergic Conjunctivitis Market Overview

Allergic conjunctivitis is an eye fixed inflammation caused by an allergy because of allergens like pollen or mold spores, dust mites and animal fur. The eyeball features a membrane called conjunctiva which is vulnerable to irritation from allergens. Allergic conjunctivitis is that the body’s reaction to substances which are potentially harmful. There are differing types of allergic conjunctivitis like seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conjunctivitis and atopic kerato conjunctivitis. A number of the symptoms of allergic conjunctivitis are red, itchy, watery and burning eyes. Allergic conjunctivitis is often treated by oral medications, eye drops or immunotherapy.

The Allergic Conjunctivitis Market accounted for US$ 2.6 billion in 2020 and is estimated to be US$ 4.2 billion by 2029 and is anticipated to register a CAGR of 5.3%.

Impact of Covid-19 pandemic on market

With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the product segment. Government across the countries has imposed strict lockdown to limit the spread of disease. The pandemic has hugely impacted the pharmaceutical sectors due strong decline in the hospital visits as per the government’s norms and condition. This is especially critical for the drugs market as several non-essential and non-critical medical procedures have been postponed in light of the pandemic. This report will quantify the impact of pandemic on allergic conjunctivitis market.

Global Allergic Conjunctivitis Market Dynamics

The global allergic conjunctivitis treatment market is also driven by rise in air pollution in major cities across the globe. A research study published in 2016 by the National Center for Biotechnology Information (NCBI) revealed that ambient air pollution and weather changes are responsible for the occurrence as well as worsening of allergic conjunctivitis. This is attributed to the conjunctiva being sensitive to environmental particles along with direct contact of conjunctiva with the outside environment. Hence, rise in air pollution propels the global allergic conjunctivitis treatment market.

Development of new treatment options

Pharmaceutical companies are developing new treatment options for allergic conjunctivitis such as Zerviate, EM-100, ADX-102, PRT-2761, and OTX-DP. For instance, EyeMax LLC’s EM-100 is currently in phase 3 of clinical trial, where its effectiveness is being checked in the treatment of ocular itching. Presently, around two third of new treatment options are in phase 2 or 3 of clinical trials. All these studies are being sponsored by major pharmaceutical companies. These factors fuel the growth of the global allergic conjunctivitis treatment market. Furthermore, factors such as appropriate diagnosis for viral conjunctivitis and limited awareness regarding advanced technologies are hampering the growth of the global market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Allergic Conjunctivitis Market Segmentation

The global allergic conjunctivitis market is segmented based on type, drug class, end 

On the basis of type, the global allergic conjunctivitis market is segmented into bacterial, allergic, viral, and chemical. Based on drug class, the target market is segmented into antibiotics, mast cell stabilizers, steroids, and others. Based on end user, the target market segmented into hospitals and clinics and specialty centers.

On region the global allergic conjunctivitis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest market for allergic conjunctivitis treatments due to high prevalence of allergic conjunctivitis. According to the American Society of Cataract and Refractive Surgery (ASCRS), around 50 million to 60 million people in the U.S. had allergic conjunctivitis in 2015. Moreover, the allergic conjunctivitis treatment market in Asia Pacific is expected to grow at a rapid pace due to large population base leading to increase in demand for improved health care facilities.

 

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Type- Bacterial, Allergic, Viral, and Chemical

By Drug Class- Antibiotics, Mast Cell Stabilizers, Steroids, and others

By End User- Hospitals and Clinics and Specialty Centers

Delivery Mode Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global allergic conjunctivitis market report based on type, drug class, end user and region.

Global Allergic Conjunctivitis Market, By Type:

  • Bacterial
  • Allergic
  • Viral
  • Chemical

Global Allergic Conjunctivitis Market, By Drug Class:

  • Antibiotics
  • Mast Cell Stabilizers
  • Steroids
  • others

Global Allergic Conjunctivitis Market, By End User:

  • Hospitals and Clinics
  • Specialty Centers

Global Allergic Conjunctivitis Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Allergic Conjunctivitis Market Key Players

The key players operating in the global allergic conjunctivitis market includes Akorn Incorporated, Allergan, Bausch Health Companies, Inc., Novartis AG, Santen Pharmaceutical Co. Ltd., Sun Pharma Advanced Research Company Ltd., Ocular Therapeutix, Inc., Sirion Therapeutics, Inc., Boehringer Ingelheim International GmbH, Atopix Therapeutics Ltd., and Auven Therapeutics. The market is especially characterized by collaborations and partnerships between the businesses and acquisitions of smaller players as a part of strategic expansion as well as launching their new product specimen. For instance, in April 2020, Alembic Pharmaceuticals Limited announced that the company had received an abbreviated new drug application (ANDA) approval from the FDA for their generic ophthalmic solution of alcaftadine for the disease indication of allergic conjunctivitis.

Global Allergic Conjunctivitis Market Company Profile

  • Akorn Incorporated
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Allergan
  • Bausch Health Companies, Inc.
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharma Advanced Research Company Ltd.
  • Ocular Therapeutix, Inc.
  • Sirion Therapeutics, Inc.
  • Boehringer Ingelheim International GmbH
  • Atopix Therapeutics Ltd.
  • Auven Therapeutics

Global Allergic Conjunctivitis Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Allergic Conjunctivitis Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Drug Class
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Allergic Conjunctivitis Market, By Type, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Bacterial
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Allergic
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Viral
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Chemical
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  6. Global Allergic Conjunctivitis Market, By Drug Class, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Antibiotics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Mast Cell Stabilizers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Steroids
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  7. Global Allergic Conjunctivitis Market, By End User, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Hospitals and Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Specialty Centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  8. Global Allergic Conjunctivitis Market, By Region, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Sizeand Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By Drug Class, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Sizeand Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By Drug Class, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Sizeand Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By Drug Class, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Sizeand Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By Drug Class, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Sizeand Forecast (US$ Mn), By Type, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By Drug Class, 2019 – 2029
      • Market Sizeand Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • Akorn Incorporated
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Allergan
      • Bausch Health Companies, Inc.
      • Novartis AG
      • Santen Pharmaceutical Co. Ltd.
      • Sun Pharma Advanced Research Company Ltd.
      • Ocular Therapeutix, Inc.
      • Sirion Therapeutics, Inc.
      • Boehringer Ingelheim International GmbH
      • Atopix Therapeutics Ltd.
      • Auven Therapeutics
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Global Allergic Conjunctivitis Market is segmented based on type, drug class, end-user and region.

The global allergic conjunctivitis treatment market is also driven by rise in air pollution in major cities across the globe.

North America is the largest market for allergic conjunctivitis treatments due to high prevalence of allergic conjunctivitis.

The key players operating in the global allergic conjunctivitis market includes Akorn Incorporated, Allergan, Bausch Health Companies, Inc., Novartis AG, Santen Pharmaceutical Co. Ltd., Sun Pharma Advanced Research Company Ltd., Ocular Therapeutix, Inc., Sirion Therapeutics, Inc., Boehringer Ingelheim International GmbH, Atopix Therapeutics Ltd., and Auven Therapeutics.